Maternal Outcomes

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Moderna
ModernaCAMBRIDGE, MA
1 program
Study to Assess Maternal and Infant Outcomes Following Exposure to SPIKEVAX During PregnancyN/A1 trial
Active Trials
NCT06369272Completed1,192Est. Oct 2023

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
ModernaStudy to Assess Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy

Clinical Trials (1)

Total enrollment: 1,192 patients across 1 trials

NCT06369272ModernaStudy to Assess Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy

Study to Assess Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy

Start: Mar 2023Est. completion: Oct 20231,192 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space